Literature DB >> 16160812

["Fatigue" in multiple sclerosis. Development and and validation of the "Würzburger Fatigue Inventory for MS"].

P Flachenecker1, G Müller, H König, H Meissner, K V Toyka, P Rieckmann.   

Abstract

BACKGROUND: Fatigue is one of the most common, yet poorly defined, disabling symptoms in patients with multiple sclerosis (MS). Several fatigue scales have been developed, but rigorous psychometric methods have not always been applied and validation was mainly based on small numbers of patients. We therefore assembled a new fatigue scale from a set of widely used scales and assessed its psychometric properties in a large sample of MS patients. PATIENTS AND METHODS: Fatigue was assessed in 158 MS patients by four published quantitative scales: the Fatigue Severity Scale (FSS), Modified Fatigue Impact Scale (MFIS), MS-specific Fatigue Severity Scale (MFSS), and Visual Analogue Scale. From these a new fatigue scale, the Würzburg Fatigue Inventory for Multiple Sclerosis (WEIMuS), was assembled. It contains 17 items with values from 0 to 4. The WEIMuS scale was validated in a subgroup of 67 patients and a control group of 68 patients.
RESULTS: The MFIS and FSS but not the MFSS showed high internal consistency and split-half reliability. After applying factor analysis within the scales, fairly reliable and valid items originally found in the MFIS and FSS were selected to construct the final 17-item WEIMuS scale, which showed a high degree of reliability. In the validation study, varimax rotated factor analysis extracted two main factors corresponding to both cognitive and physical fatigue.
CONCLUSION: The new, two-dimensional WEIMuS showed good psychometric properties, is easy to use, and may therefore be a useful tool for the assessment of MS-associated fatigue. Multiple sclerosis patients suffer from different types of fatigue which could be attributed to cognitive and physical fatigue. Thus, MS-associated fatigue is different from common tiredness.

Entities:  

Mesh:

Year:  2006        PMID: 16160812     DOI: 10.1007/s00115-005-1990-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  12 in total

Review 1.  ['Fatigue' in multiple sclerosis].

Authors:  C Zimmermann; R Hohlfeld
Journal:  Nervenarzt       Date:  1999-06       Impact factor: 1.214

2.  Is fatigue in patients with multiple sclerosis related to autonomic dysfunction?

Authors:  L Keselbrener; S Akselrod; A Ahiron; M Eldar; Y Barak; Z Rotstein
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

3.  Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.

Authors:  P Flachenecker; T Kümpfel; B Kallmann; M Gottschalk; O Grauer; P Rieckmann; C Trenkwalder; K V Toyka
Journal:  Mult Scler       Date:  2002-12       Impact factor: 6.312

4.  Evaluation of the Modified Fatigue Impact Scale in four different European countries.

Authors:  D Kos; E Kerckhofs; I Carrea; R Verza; M Ramos; J Jansa
Journal:  Mult Scler       Date:  2005-02       Impact factor: 6.312

5.  Treating fatigue in patients with MS: one step forward, one step back.

Authors:  Steven R Schwid; T Jock Murray
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

6.  Fatigue in multiple sclerosis and its relationship to depression and neurologic disability.

Authors:  R Bakshi; Z A Shaikh; R S Miletich; D Czarnecki; J Dmochowski; K Henschel; V Janardhan; N Dubey; P R Kinkel
Journal:  Mult Scler       Date:  2000-06       Impact factor: 6.312

7.  Fatigue in multiple sclerosis.

Authors:  L B Krupp; L A Alvarez; N G LaRocca; L C Scheinberg
Journal:  Arch Neurol       Date:  1988-04

8.  The impact of fatigue on patients with multiple sclerosis.

Authors:  J D Fisk; A Pontefract; P G Ritvo; C J Archibald; T J Murray
Journal:  Can J Neurol Sci       Date:  1994-02       Impact factor: 2.104

9.  Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.

Authors:  L B Krupp; P K Coyle; C Doscher; A Miller; A H Cross; L Jandorf; J Halper; B Johnson; L Morgante; R Grimson
Journal:  Neurology       Date:  1995-11       Impact factor: 9.910

10.  Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis.

Authors:  M J Taphoorn; E van Someren; F J Snoek; R L Strijers; D F Swaab; F Visscher; L P de Waal; C H Polman
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

View more
  31 in total

1.  Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial.

Authors:  Rosaria Sacco; Rita Bussman; Peter Oesch; Jürg Kesselring; Serafin Beer
Journal:  J Neurol       Date:  2010-11-15       Impact factor: 4.849

2.  Objective assessment of motor fatigue in multiple sclerosis: the Fatigue index Kliniken Schmieder (FKS).

Authors:  Aida Sehle; Manfred Vieten; Simon Sailer; Annegret Mündermann; Christian Dettmers
Journal:  J Neurol       Date:  2014-06-22       Impact factor: 4.849

3.  Altered serotonin transporter availability in patients with multiple sclerosis.

Authors:  Swen Hesse; Franziska Moeller; David Petroff; Donald Lobsien; Julia Luthardt; Ralf Regenthal; Georg-Alexander Becker; Marianne Patt; Eva Thomae; Anita Seese; Philipp M Meyer; Florian Then Bergh; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

4.  Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention.

Authors:  Jana Pöttgen; Stephanie Lau; Iris Penner; Christoph Heesen; Steffen Moritz
Journal:  Int J MS Care       Date:  2015 May-Jun

5.  Trait mindfulness is primarily associated with depression and not with fatigue in multiple sclerosis (MS): implications for mindfulness-based interventions.

Authors:  Torsten Sauder; Philipp M Keune; Roy Müller; Thomas Schenk; Patrick Oschmann; Sascha Hansen
Journal:  BMC Neurol       Date:  2021-03-16       Impact factor: 2.474

6.  An exploration of impaired walking dynamics and fatigue in multiple sclerosis.

Authors:  Janina M Burschka; Philipp M Keune; Uwe Menge; Ulrich Hofstadt-van Oy; Patrick Oschmann; Olaf Hoos
Journal:  BMC Neurol       Date:  2012-12-27       Impact factor: 2.474

7.  Local dynamic stability as a responsive index for the evaluation of rehabilitation effect on fall risk in patients with multiple sclerosis: a longitudinal study.

Authors:  Roger Hilfiker; Claude Vaney; Brigitte Gattlen; André Meichtry; Olivier Deriaz; Véronique Lugon-Moulin; Anne-Marie Anchisi-Bellwald; Cécilia Palaci; Denise Foinant; Philippe Terrier
Journal:  BMC Res Notes       Date:  2013-07-09

8.  Pain in patients with multiple sclerosis: a complex assessment including quantitative and qualitative measurements provides for a disease-related biopsychosocial pain model.

Authors:  Dominik Michalski; Stefanie Liebig; Eva Thomae; Andreas Hinz; Florian Then Bergh
Journal:  J Pain Res       Date:  2011-08-02       Impact factor: 3.133

Review 9.  Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: a systematic review of measurement properties.

Authors:  Roy G Elbers; Marc B Rietberg; Erwin E H van Wegen; John Verhoef; Sharon F Kramer; Caroline B Terwee; Gert Kwakkel
Journal:  Qual Life Res       Date:  2011-10-20       Impact factor: 4.147

10.  Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis.

Authors:  Annett Kunkel; Martin Fischer; Judith Faiss; Doreen Dähne; Wolfgang Köhler; Jürgen H Faiss
Journal:  Front Neurol       Date:  2015-05-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.